KineMed, Inc. Announces Extension of Its Collaboration with Bristol-Myers Squibb Company

March 9, 2011 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed, Inc. (www.kinemed.com) announced today the extension of its collaboration with Bristol-Myers Squibb (NYSE: BMY) in the area of Alzheimer’s disease and other neurodegenerative conditions.

Twitter
LinkedIn
Facebook
Email
Print

Alliances

Bristol Myers Squibb Company